These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3050231)

  • 1. [Physiopathology of non-insulin-dependent diabetes. New therapeutic approaches with gliclazide].
    Lesobre B
    Journ Annu Diabetol Hotel Dieu; 1988; ():337-47. PubMed ID: 3050231
    [No Abstract]   [Full Text] [Related]  

  • 2. [Non-insulin-dependent diabetes and gliclazide].
    Lesobre B
    Journ Annu Diabetol Hotel Dieu; 1986; ():295-301. PubMed ID: 3302488
    [No Abstract]   [Full Text] [Related]  

  • 3. Gliclazide modified release: its place in the therapeutic armamentarium.
    Crepaldi G; Fioretto P
    Metabolism; 2000 Oct; 49(10 Suppl 2):21-5. PubMed ID: 11078472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physiopathology of non insulin-dependent diabetes. Action of gliclazide].
    Lesobre B
    Journ Annu Diabetol Hotel Dieu; 1985; ():319-23. PubMed ID: 2577975
    [No Abstract]   [Full Text] [Related]  

  • 5. [Insulinotropic effect of diamicron after oral fructose tolerance test in patients with non-insulin-dependent diabetes mellitus].
    Balabolkin MI; Levitskaia ZI; Morozova TP; Zhizhina SA; Gavriliuk LI
    Probl Endokrinol (Mosk); 1983; 29(5):8-12. PubMed ID: 6359134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of gliclazide on non-insulin dependent diabetes mellitus.
    Wajchenberg BJ; Santomaruo AT; Cherem JJ; Malerbi DA; Giurno Filho A; Lerario AC; Giannella Neto D
    Adv Exp Med Biol; 1988; 246():313-9. PubMed ID: 3074661
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preliminary report on 30 cases of non-insulin-dependent diabetes (NIDD) treated with gliclazide].
    Pan CY
    Zhonghua Nei Ke Za Zhi; 1983 Jul; 22(7):426-8. PubMed ID: 6641388
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical efficacy of glimepiride].
    Kaneko T; Sakamoto N
    Nihon Rinsho; 1997 Nov; 55 Suppl():152-7. PubMed ID: 9434460
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of middle-term gliclazide treatment on insulin secretion in non-insulin dependent diabetics.
    Brogard JM; Pinget M; Dorner M
    Curr Med Res Opin; 1984; 9(1):56-63. PubMed ID: 6373160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of long term gliclazide administration on insulin secretion and insulin sensitivity.
    Ma A; Kamp M; Bird D; Howlett V; Cameron DP
    Aust N Z J Med; 1989 Feb; 19(1):44-9. PubMed ID: 2669710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of long-term therapy with sulfanylurea preparations on the relation of insulin secretion and the insulin-binding capacity of its receptors].
    Balabolkin MI; Nedosugova LV
    Ter Arkh; 1988; 60(12):91-6. PubMed ID: 3150136
    [No Abstract]   [Full Text] [Related]  

  • 12. Gliclazide therapy is associated with potentiation of postbinding insulin action in obese, non-insulin-dependent diabetic subjects.
    Ward G; Harrison LC; Proietto J; Aitken P; Nankervis A
    Diabetes; 1985 Mar; 34(3):241-5. PubMed ID: 3882491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The importance of gliclazide in clinical practice].
    Svoboda Z
    Vnitr Lek; 1988 Jun; 34(6):581-5. PubMed ID: 3414038
    [No Abstract]   [Full Text] [Related]  

  • 14. Gliclazide--oral hypoglycaemic agent.
    Aust Nurses J; 1985 Sep; 15(3):57-8. PubMed ID: 3852674
    [No Abstract]   [Full Text] [Related]  

  • 15. Gliclazide: a new sulphonylurea.
    Sullivan JT; Smith RB
    N Z Med J; 1984 Jan; 97(747):22-3. PubMed ID: 6361631
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of gliquidone--short acting sulfonylurea derivative--comparison with glibenclamide and gliclazide].
    Rupprecht E; König E; Limmer J
    Pol Tyg Lek; 1993 Apr; 48 Suppl 1():31-2. PubMed ID: 8516203
    [No Abstract]   [Full Text] [Related]  

  • 17. Gliclazide on long-term therapy increases insulin response to glucose of type II diabetics.
    Couturier E
    Diabetes Res Clin Pract; 1985-1986 Mar; 1(6):343-7. PubMed ID: 3915271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New oral hypoglycemic drug--gliclazide--in the treatment of maturity onset diabetes mellitus.
    Patel JC; Vikani AV
    Indian J Med Sci; 1988 Mar; 42(3):53-9. PubMed ID: 3410515
    [No Abstract]   [Full Text] [Related]  

  • 19. [Gliclazide, a new molecule in the treatment of non-insulin-dependent diabetes mellitus].
    Bour H
    Rev Prat; 1980 Feb; 30(9):593-4. PubMed ID: 7361055
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of short term hypoglycemic treatment with gliclazide and gliquidone on platelet function in patients with diabetes mellitus type II].
    Grzeszczak W; Strojek K
    Pol Tyg Lek; 1993 Apr; 48 Suppl 1():38-9. PubMed ID: 8516206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.